Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (1137)	12/5/2001 8:38:31 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 1475

This is a minor issue, but knowing something about exhibit space...size and location as being indications as to what exhibitors hope from an exhibit, I find it interesting that BTRN has two well located exhibits spaces for the upcoming ASH conference. Most companies only have one space...some of the major drug companies have three or four but for the small biotechs the reservations indicate only one space. However, it appears that Gambro has the two adjacent spaces to BTRN...indicating that they have big plans for the Eligix system being a focal point for their exhibit. Bottomline, it appears that BTRN and Gambro with 4 connected spaces, will be one of the larger exhibitors at ASH. They have spaces...673, 674, 675, 676.